Exogen Limited is a visa-eligible skilled worker company focused on discovery and development within the biotechnology sector. Established in November 2019 with Reg. number 12293407, Exogene Ltd. operates internationally from its headquarters at International House, London (EC3V 3NG). The company’s primary business involves comprehensive research and experimental development utilizing cutting-edge technologies. Exogen specializes in providing a data-driven approach to understanding complex biological systems through advanced analytics – including competitor monitoring, market trend analysis, and detailed company profile generation. Their core focus centers on identifying novel therapeutic targets and optimizing drug candidates for potential clinical trials. The company’s key industry involvement spans research, development, and testing within biotechnology, pharmaceutical, and medical device sectors. Exogen Ltd. leverages a team of highly skilled scientists, researchers, and technical experts. The company is actively expanding its international presence through strategic partnerships and collaborations. Exogene Ltd. currently employs approximately 50 individuals across multiple locations. They maintain a strong commitment to innovation and are seeking to expand their operations globally. Stock symbol: EXON.

Exogen Limited is a visa-eligible skilled worker company focused on discovery and development within the biotechnology sector. Established in November 2019 with Reg. number 12293407, Exogene Ltd. operates internationally from its headquarters at International House, London (EC3V 3NG). The company’s primary business involves comprehensive research and experimental development utilizing cutting-edge technologies. Exogen specializes in providing a data-driven approach to understanding complex biological systems through advanced analytics – including competitor monitoring, market trend analysis, and detailed company profile generation. Their core focus centers on identifying novel therapeutic targets and optimizing drug candidates for potential clinical trials. The company’s key industry involvement spans research, development, and testing within biotechnology, pharmaceutical, and medical device sectors. Exogen Ltd. leverages a team of highly skilled scientists, researchers, and technical experts. The company is actively expanding its international presence through strategic partnerships and collaborations. Exogene Ltd. currently employs approximately 50 individuals across multiple locations. They maintain a strong commitment to innovation and are seeking to expand their operations globally. Stock symbol: EXON.